Terms: = Pancreatic cancer AND EZR, CVIL, 7430, ENSG00000092820, P15311, MGC1584, FLJ26216, DKFZp762H157, CVL AND Prognosis
3 results:
1. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells.
Lipreri da Silva JC; Carvalho MFL; de Miranda LBL; de Almeida BO; Lima K; Machado-Neto JA
Invest New Drugs; 2022 Aug; 40(4):728-737. PubMed ID: 35477813
[TBL] [Abstract] [Full Text] [Related]
2. Autoantibody-targeted TAAs in pancreatic cancer: A comprehensive analysis.
Zhou Y; Cui J; Du H
Pancreatology; 2019 Jul; 19(5):760-768. PubMed ID: 31255446
[TBL] [Abstract] [Full Text] [Related]
3. Suprapubic approach for robotic complete mesocolic excision in right colectomy: Oncologic safety and short-term outcomes of an original technique.
Petz W; Ribero D; Bertani E; Borin S; Formisano G; Esposito S; Spinoglio G; Bianchi PP
Eur J Surg Oncol; 2017 Nov; 43(11):2060-2066. PubMed ID: 28912072
[TBL] [Abstract] [Full Text] [Related]
